 Oral terbinafine versus griseofulvin treatment moccasin-type tinea pedis safety effectiveness oral terbinafine mg griseofulvin mg patients moccasin-type tinea pedis double-blind randomized trial end treatment period clinical mycologic cure mycologic cure minimal signs infection terbinafine-treated patients patients griseofulvin overall response rate weeks completion treatment terbinafine-treated group griseofulvin-treated group months completion study terbinafine-treated patients sustained clearing tinea pedis nail involvement time treatment improvement contrast tinea pedis patients griseofulvin onychomycosis